Highlights
NASDAQ: CATB       Catabasis Pharma
Last Price Today's Change   Day's Range   Trading Volume
5.56   +0.06 (1.09%)  5.43 - 5.64  67,693

Overview

 
Avg Volume (4 weeks):108,138
4 Weeks Range:4.83 - 6.431
4 Weeks Price Volatility (%):
45.60%
52 Weeks Range:0.36 - 9.76
52 Weeks Price Volatility (%):
55.32%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Catabasis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of therapeutics based on its Safely Metabolized And Rationally Targeted, a linker drug discovery platform. The company's primary focus is on treatments for rare diseases. Its product pipeline includes CAT-1004, an oral small molecule for the treatment of duchenne muscular dystrophy, CAT-2054 for the treatment of hypercholesterolemia and CAT-4001 which is used for the treatment of rare neurodegenerative diseases, such as Friedreich's ataxia and amyotrophic lateral sclerosis. Geographically it operates thorough United States and derives revenue from sale of products.

  Be the first to like this.
 


 

3629  2097  326  2919 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 11.44+0.47 
 AMD 42.59+3.12 
 DHR 151.30+1.63 
 CHK 0.783+0.038 
 BAC 34.67+1.03 
 FCEL 0.707+0.144 
 AMRX 5.04+1.56 
 AABA 19.630.00 
 F 9.32+0.21 
Partners & Brokers